These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30983747)

  • 1. Persistent Metabolic Acidosis on Regular Hemodialysis or Peritoneal Dialysis.
    Goutham KTC; Harichandrakumar KT; Dhanin P; Priyamvada PS; Haridasan S; Parameswaran S
    Indian J Nephrol; 2019; 29(2):84-89. PubMed ID: 30983747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of uremic acidosis in hemodialysis patients with a high bicarbonate dialysate.
    Oettinger CW; Oliver JC
    J Am Soc Nephrol; 1993 May; 3(11):1804-7. PubMed ID: 8329675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients.
    Brady JP; Hasbargen JA
    Am J Kidney Dis; 1998 Jan; 31(1):35-40. PubMed ID: 9428449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients.
    Yamamoto T; Shoji S; Yamakawa T; Wada A; Suzuki K; Iseki K; Tsubakihara Y
    Am J Kidney Dis; 2015 Sep; 66(3):469-78. PubMed ID: 26015276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dialysate potassium and lactate on serum potassium and bicarbonate concentrations during daily hemodialysis at low dialysate flow rates.
    Leypoldt JK; Kraus MA; Jaber BL; Weinhandl ED; Collins AJ
    BMC Nephrol; 2019 Jul; 20(1):252. PubMed ID: 31288787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Bommer J; Locatelli F; Satayathum S; Keen ML; Goodkin DA; Saito A; Akiba T; Port FK; Young EW
    Am J Kidney Dis; 2004 Oct; 44(4):661-71. PubMed ID: 15384017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
    Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
    Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality.
    Vashistha T; Kalantar-Zadeh K; Molnar MZ; Torlén K; Mehrotra R
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):254-64. PubMed ID: 23184567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Bicarbonate-Buffered Dialysate on Ventricular Arrhythmias in Hemodialysis Patients.
    Krahn RE; Tulowitzki R; Gudleski GD; Murray B; Rajagopalan B; Su W; Muscarella M; Lambert J; Curtis AB; Panesar M
    Am J Nephrol; 2019; 49(1):74-80. PubMed ID: 30602157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varying Dialysate Bicarbonate Concentrations in Maintenance Hemodialysis Patients Affect Post-dialysis Alkalosis but not Pre-dialysis Acidosis.
    Noh US; Yi JH; Han SW; Kim HJ
    Electrolyte Blood Press; 2007 Dec; 5(2):95-101. PubMed ID: 24459507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic acidosis in hemodialysis patients: a study of prevalence and factors affecting intradialytic bicarbonate gain.
    Sepandj F; Jindal K; Kiberd B; Hirsch D
    Artif Organs; 1996 Sep; 20(9):976-80. PubMed ID: 8864017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of metabolic acidosis to ameliorate wasting in chronic kidney disease: goals and strategies.
    Chiu YW; Kopple JD; Mehrotra R
    Semin Nephrol; 2009 Jan; 29(1):67-74. PubMed ID: 19121476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral sodium bicarbonate supplementation on interdialytic weight gain, plasma sodium concentrations and predialysis blood pressure in hemodialysis patients.
    Movilli E; Gaggia P; Camerini C; Brunori G; Vizzardi V; Cancarini G
    Blood Purif; 2005; 23(5):379-83. PubMed ID: 16088106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum bicarbonate with bone fractures in hemodialysis patients: the mineral and bone disorder outcomes study for Japanese CKD stage 5D patients (MBD-5D).
    Kato A; Kido R; Onishi Y; Kurita N; Fukagawa M; Akizawa T; Fukuhara S
    Nephron Clin Pract; 2014; 128(1-2):79-87. PubMed ID: 25378374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study.
    Movilli E; Zani R; Carli O; Sangalli L; Pola A; Camerini C; Scolari F; Cancarini GC; Maiorca R
    Nephron; 2001 Mar; 87(3):257-62. PubMed ID: 11287761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure.
    Kalantar-Zadeh K; Mehrotra R; Fouque D; Kopple JD
    Semin Dial; 2004; 17(6):455-65. PubMed ID: 15660576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of metabolic acidosis among hemodialysis patients.
    Soudan K; Ricanati ES; Leon JB; Sehgal AR
    Hemodial Int; 2006 Apr; 10(2):209-14. PubMed ID: 16623676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Serum Bicarbonate Levels Caused by Acetate-Containing Bicarbonate-Buffered Hemodialysis Solution: An Observational Prospective Cohort Study.
    Panesar M; Shah N; Vaqar S; Ivaturi K; Gudleski G; Muscarella M; Lambert J; Su W; Murray B
    Ther Apher Dial; 2017 Apr; 21(2):157-165. PubMed ID: 28296160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro: Higher serum bicarbonate in dialysis patients is protective.
    Misra M
    Nephrol Dial Transplant; 2016 Aug; 31(8):1220-4. PubMed ID: 27411723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
    Tangri N; Mathur VS; Bushinsky DA; Klaerner G; Li E; Parsell D; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Perkovic V; Inker LA
    J Am Soc Nephrol; 2024 Mar; 35(3):311-320. PubMed ID: 38261535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.